Medical News Bulletin - Edition 4

There’s a new intranasal vaccine for COVID-19 - iNCOVACC. It is the world’s first intranasal vaccine for COVID. 

Yes, the field of medicine is continuously evolving and we would like you to stay updated with all important advancements. Hence, this blog. Here you’ll find some of the most important and latest medical news in brief. 

Read this blog further to catch up with all the latest updates from the healthcare industry. 

Genes To Determine Coronary Heart Disease Risks

A recent study published in the journal “Circulation: Genomic and Precision Medicine” revealed the most critically important genes that cause coronary heart disease and heart attacks. 

The study achieved three major breakthroughs, which hold key importance in treatment and prevention of coronary heart disease. Some of the top genes identified were never really studied before in context to heart diseases. 

Since coronary heart disease is the world’s leading cause of death, the findings from this recent study has paved the way for a new field of tailored medicine to help high risk patients. 

News Source

DOACs Better Than LMWH For Cancer-Associated Thrombosis

Researchers have found that Direct Oral Anticoagulants (DOACs) are both more medically and cost-effective than Low-Molecular Weight Heparin (LMWH) when treating Cancer-Associated Thrombosis (CAT).

The findings of this research which was published in the Annals of Internal Medicine may inform decisions on clinical level and policy decisions as well.

News Source

Winters Increase The Risk Of Heart Issues

In comparison to normal weather, the human body temperature during winters falls. Due to which the heart has to work extra to maintain the body temperature. This in turn narrows the blood vessels, increasing the risk of heart issues. People with high blood pressure, increased cholesterol, unhealthy lifestyle habits and heart related family history are at the highest risk.

News Source

World’s First COVID Intranasal Vaccine

Bharat Biotech International Limited has developed the world’s first intranasal COVID vaccine that has received approval for primary two-dose schedule and as a heterologous booster dose. 

The COVID Intranasal Vaccine— iNCOVACC is priced at ₹800 (excluding GST) for private markets and ₹325 (excluding GST) for government supplies. 

News Source

Also Read: 

Medical News Bulletin Edition 1, Edition 2, Edition 3

Stay tuned for regular updates on latest medical news and technological advancements from the healthcare industry.